Assignee
INTELGENX CORP
CA18 patents
Top patents by PatentIndex Score
US7674479B2Mar 9, 2010
Sustained-release bupropion and bupropion/mecamylamine tablets
INTELGENX CORP137 citations97
US7132113B2Nov 7, 2006
Flavored film
INTELGENX CORP42 citations93
US10272038B2Apr 30, 2019
Film dosage form with extended release mucoadhesive particles
INTELGENX CORP9 citations83
US9668970B2Jun 6, 2017
Film dosage form with extended release mucoadhesive particles
INTELGENX CORP11 citations83
US9949934B1Apr 24, 2018
Device and method of treating conditions associated with neuroinflammation
INTELGENX CORP5 citations82
US11033493B2Jun 15, 2021
Film dosage form with extended release mucoadhesive particles
INTELGENX CORP5 citations81
US10722476B2Jul 28, 2020
Device and method of treating conditions associated with neuroinflammation
INTELGENX CORP3 citations71
US9301948B2Apr 5, 2016
Instantly wettable oral film dosage form without surfactant or polyalcohol
INTELGENX CORP4 citations70
US11602504B2Mar 14, 2023
Lipophilic active oral film formulation and method of making the same
INTELGENX CORP4 citations69
US11471406B2Oct 18, 2022
Oral film formulation for modulating absorption profile
INTELGENX CORP3 citations69
US10828254B2Nov 10, 2020
Oral film formulation for modulating absorption profile
INTELGENX CORP4 citations69
US11648212B2May 16, 2023
Loxapine film oral dosage form
INTELGENX CORP3 citations68
US9717682B2Aug 1, 2017
Solid oral film dosage forms and methods for making same
INTELGENX CORP3 citations67
US10610528B2Apr 7, 2020
Solid oral film dosage forms and methods for making same
INTELGENX CORP3 citations66
US11957785B2Apr 16, 2024
Film dosage form with extended release mucoadhesive particles
INTELGENX CORP0 citations59
US12156937B2Dec 3, 2024
Oral film formulation for modulating absorption profile
INTELGENX CORP0 citations58
US12303501B2May 20, 2025
Lipophilic active oral film formulation and method of making the same
INTELGENX CORP0 citations57
US12440472B2Oct 14, 2025
Stable tryptamine oral films
INTELGENX CORP0 citations55